Truist Financial Lowers Aveanna Healthcare (NASDAQ:AVAH) Price Target to $9.00

Aveanna Healthcare (NASDAQ:AVAH) had its price target cut by equities researchers at Truist Financial from $10.00 to $9.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price points to a potential upside of 38.04% from the stock’s previous close.

Several other analysts have also recently issued reports on AVAH. Royal Bank Of Canada increased their target price on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a research note on Thursday, January 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. UBS Group upped their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, January 15th. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Finally, William Blair assumed coverage on Aveanna Healthcare in a research note on Monday, December 8th. They set an “outperform” rating for the company. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $10.81.

Aveanna Healthcare Trading Up 2.8%

Shares of Aveanna Healthcare stock opened at $6.52 on Friday. The company’s 50-day moving average price is $7.84 and its 200-day moving average price is $8.49. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. Aveanna Healthcare has a 12-month low of $3.73 and a 12-month high of $10.32. The company has a market cap of $1.36 billion, a price-to-earnings ratio of 6.39 and a beta of 2.07.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, CEO Jeff Shaner sold 173,225 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the completion of the transaction, the chief executive officer owned 2,650,892 shares of the company’s stock, valued at $19,112,931.32. The trade was a 6.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Deborah Stewart sold 11,181 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $80,615.01. Following the completion of the transaction, the chief accounting officer directly owned 301,807 shares in the company, valued at $2,176,028.47. The trade was a 3.57% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 998,595 shares of company stock valued at $7,567,770 over the last quarter. Company insiders own 7.80% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd raised its position in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after purchasing an additional 2,400 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare during the 2nd quarter valued at about $43,000. Lion Street Advisors LLC purchased a new position in shares of Aveanna Healthcare during the 3rd quarter valued at about $89,000. EverSource Wealth Advisors LLC raised its holdings in shares of Aveanna Healthcare by 88,100.0% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock valued at $102,000 after buying an additional 11,453 shares in the last quarter. Finally, State of Alaska Department of Revenue bought a new stake in Aveanna Healthcare in the 3rd quarter worth approximately $106,000. Institutional investors own 87.96% of the company’s stock.

Key Stories Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results beat consensus — revenue grew strongly year‑over‑year and the company topped EPS and revenue estimates, providing fundamental support for the stock. Press Release
• Positive Sentiment: Raymond James upgraded AVAH to “strong-buy” and set a $13 price target, which is a bullish catalyst and likely helping intraday buying interest. Finviz item
• Neutral Sentiment: BMO trimmed its price target from $11 to $10 but maintained an “outperform” rating — a modest pullback in upside but not a negative rating change. Benzinga
• Neutral Sentiment: Aveanna issued 2026 guidance and a growth outlook; the details are being parsed by investors and helped explain the mixed market reaction (earnings beat vs. cautious forward commentary). TipRanks
• Neutral Sentiment: Reported short‑interest entries show anomalous “0 shares”/NaN data for March (data likely erroneous), so short‑interest signals are not meaningful right now.
• Negative Sentiment: Truist lowered its price target to $9 and moved to a “hold” rating, reducing analyst support and putting downside pressure on the stock. Benzinga
• Negative Sentiment: Market headlines flagged that Aveanna’s revenue outlook/trend in guidance trailed some consensus expectations, which prompted a pullback in some coverage and weighed on sentiment. MSN

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.